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Abstract
Background: Anthrax meningitis is the main neurological complication of systemic infection with Bacillus anthracis
approaching 100% mortality. The presence of bacilli in brain autopsies indicates that vegetative bacteria are able to breach
the blood-brain barrier (BBB). The BBB represents not only a physical barrier but has been shown to play an active role in
initiating a specific innate immune response that recruits neutrophils to the site of infection. Currently, the basic pathogenic
mechanisms by which B. anthracis penetrates the BBB and causes anthrax meningitis are poorly understood.
Methodology/Principal Findings: Using an in vitro BBB model, we show for the first time that B. anthracis efficiently invades
human brain microvascular endothelial cells (hBMEC), the single cell layer that comprises the BBB. Furthermore,
transcriptional profiling of hBMEC during infection with B. anthracis revealed downregulation of 270 (87%) genes,
specifically key neutrophil chemoattractants IL-8, CXCL1 (Groa) and CXCL2 (Grob), thereby strongly contrasting hBMEC
responses observed with other meningeal pathogens. Further studies using specific anthrax toxin-mutants, quantitative RT-
PCR, ELISA and in vivo assays indicated that anthrax toxins actively suppress chemokine production and neutrophil
recruitment during infection, allowing unrestricted proliferation and dissemination of the bacteria. Finally, mice challenged
with B. anthracis Sterne, but not the toxin-deficient strain, developed meningitis.
Conclusions/Significance: These results suggest a significant role for anthrax toxins in thwarting the BBB innate defense
response promoting penetration of bacteria into the central nervous system. Furthermore, establishment of a mouse model
for anthrax meningitis will aid in our understanding of disease pathogenesis and development of more effective treatment
strategies.
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Introduction
Bacillus anthracis is a Gram-positive spore-forming bacterium that
causes anthrax in humans and animals [1]. The recent threat of B.
anthracis as a potential bioterrorism agent has sparked renewed
interest into disease pathogenesis and treatment strategies.
Infection occurs upon entry of bacterial spores through the skin,
gastrointestinal mucosa or the lung [2]. Spores, initially taken up
by resident macrophages [3] and dendritic cells [4], germinate to
vegetative bacteria during phagocyte migration to the regional
lymph nodes. Vegetative bacteria are then released from the
phagocytes, enter the bloodstream [2] and proliferate in long
chains at preferred sites like the brain, allowing entry into the
central nervous system (CNS) and development of anthrax
meningitis. The incidence of anthrax meningitis after cutaneous
infection is approximately 5% [5], however in an outbreak of
inhalational anthrax, approximately 50% of patients displayed
signs of hemorrhagic meningitis [6]. Additionally, experimental
studies of inhalational anthrax in monkeys demonstrated menin-
gitis in 77% of cases examined [7]. In general, anthrax meningitis
is associated with a fulminant and rapidly progressive deteriorating
course approaching 100% mortality despite intensive antibiotic
therapy [5].
The major virulence factors of B. anthracis are encoded on two
native plasmids, pXO1 and pXO2 [2]. The pXO1 plasmid
contains the toxin-gene complex comprised of protective antigen
(PA), lethal factor (LF) and edema factor (EF) [1,2]. These three
toxin components combine to form two binary toxins, lethal toxin
(LT), a zinc metalloprotease that cleaves mitogen activated protein
kinases [8], and edema toxin (ET), an adenylate cyclase that
increases intracellular cyclic AMP concentrations [9]. The pXO2
plasmid encodes genes involved in the production of the
polyglutamyl capsule [1,2]. Fully virulent strains of B. anthracis
contain both plasmids, whereas the unencapsulated Sterne strain
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+, pXO2
2) is used for vaccination purposes [10]. In
addition, the Sterne strain has been widely used in both in vitro and in
vivo studies of anthrax infection as it causes lethal disease similar to
the encapsulated B. anthracis strain in mice [11]. Currently however,
no small animal model of anthrax meningitis exists that could
facilitate our understanding of disease pathogenesis and the
contribution of specific virulence factors to penetration of the CNS.
Several studies have demonstrated the presence of numerous
Gram-positive bacilli in the cerebrospinal fluid and brain [5,6],
suggesting that B. anthracis is capable of breaching the blood-brain
barrier (BBB). The human BBB, which is comprised principally of
a single layer of specialized brain microvascular endothelial cells
(BMEC), serves as a critical barrier to protect the CNS against
microbial invasion. In addition to providing barrier function, the
BBB has also been shown to play an active role in initiating a
specific innate immune response promoting neutrophil recruit-
ment [12], the clinical and diagnostic hallmark of acute bacterial
meningitis. This response is thought to be effective in clearing
bacteria from the cerebral microvasculature in the majority of
BBB encounters with bacteria. We hypothesize that penetration of
the BBB by B. anthracis likely involves bacterial invasion and
transcytosis across brain endothelium, direct damage by bacterial
toxins and/or activation of host inflammatory pathways that
compromise BBB integrity. A comprehensive study of the BBB
response to B. anthracis infection could therefore aid in our
understanding of disease pathogenesis.
In this study, we examine for the first time the interaction of B.
anthracis with the human BBB using a well established hBMEC
model [13], specific pXO1 and isogenic toxin mutants and a
newly-developed mouse model for anthrax meningitis. Our study
demonstrates that B. anthracis penetrates brain endothelium
directly and that anthrax toxins contribute to this process.
Additionally, anthrax toxins suppress the BBB neutrophil
recruitment response promoting unchecked bacterial replication
within the CNS and establishment of meningitis in a newly
developed model of hematogeneous anthrax meningitis.
Results
B. anthracis invades brain microvascular endothelial cells
Analysis of cerebral spinal fluid and brains from patients with
anthrax meningitis show the presence of numerous Gram-positive
bacilli [5,6], indicating that B. anthracis is able breach the BBB. We
hypothesized that B. anthracis, like other meningeal pathogens
[14,15], is able to invade human BMEC (hBMEC), a single-cell
layer that comprises the BBB. We therefore examined B. anthracis
Sterne interactions with hBMEC using transmission electron
microscopy (TEM). After a 1 hour infection period, bacteria were
observed in close association with the cell membrane (Fig. 1A) and
in close proximity to cell surface microvillus projections (Fig. 1B).
After further exposure numerous bacteria were found either
entering hBMEC or in membrane-bound intracellular vacuoles
(Fig. 1C–F).
To quantify the number of adherent and invasive organisms, we
optimized our previously established quantitative hBMEC adher-
ence and invasion assays [12,16] for B. anthracis. HBMEC were
grown to confluency and infected with increasing concentrations
(multiplicities of infection, MOI) of B. anthracis Sterne (MOI 1
represents approximately 1610
5 CFU); data are expressed as the
recovered total cell-associated or intracellular colony forming units
(CFU). The number of adherent bacteria steadily increased with
increasing MOI (Fig. 2A) and ranged from 25–40% of the initial
Figure 1. Transmission electron microscopy (EM) of hBMEC cells after infection with vegetative B. anthracis Sterne. (A, B) Transmission
EM showing adherent B. anthracis Sterne to the cell membrane or in close proximity to microvillus projections of hBMEC. (C, D) Vegetative B.
anthracis Sterne in the process of invading hBMEC or (E, F) inside membrane bound vesicles. Scale bar: 1 mm
doi:10.1371/journal.pone.0002964.g001
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recovered after infection with a higher MOI and longer incubation
time (Fig. 2B), representing between 2–10% of the initial
inoculum.
As the brain endothelium cells are responsible for maintaining
biochemical homeostasis within the central nervous system (CNS),
entry of molecules into the CNS is a strictly regulated process
[17,18]. However, to further demonstrate that the interaction of B.
anthracis Sterne is not just due to random uptake, we incubated
hBMEC with two related non-pathogenic Bacillus species, B.
thuringensis and B. subtilis. Both of these strains were unable to
invade hBMEC (Fig. 2C), demonstrating that the invasive ability
is specific to B. anthracis Sterne.
The EM studies suggested that B. anthracis Sterne alters the host
cytoskeleton to initiate its own uptake (Fig. 1). To confirm this
observation experimentally, invasion experiments were performed
in the presence of cytochalasin D, a potent inhibitor of cytoskeletal
rearrangements. This inhibitor has been shown previously to
effectively block invasion of hBMEC by other bacterial pathogens
[16]. As shown in Fig. 2D, addition of cytochalasin D resulted in
a dose-dependent inhibition of B. anthracis Sterne invasion into
hBMEC. Together these results suggest that B. anthracis Sterne
modulates the host cytoskeleton to induce it own uptake.
Expression profile of hBMEC following B. anthracis Sterne
infection
Understanding changes in gene expression that occur in
response to B. anthracis infection will facilitate further analysis of
anthrax meningitis pathogenesis. We performed microarray
analysis to assess the overall response of hBMEC to infection
with B. anthracis Sterne. After 6 hours of infection, 304 genes
exhibited a more than two-fold change in transcript abundance
(Table S1A, Fig 3C). Figure 3A depicts the mean differences in
total gene expression in Sterne-infected hBMEC cells compared to
uninfected cells; down- and upregulated genes in response to B.
anthracis Sterne are represented by blue and red dots, respectively.
Interestingly, the majority of affected genes (270 out-of 304, 87%)
were downregulated in response to B. anthracis Sterne infection
compared to the uninfected control (Fig 3A, C). However,
transcription was not globally impaired as 34 genes showed a more
than two fold increased expression upon infection with B. anthracis
Sterne (Fig. 3A, C, Table S1A).
Figure 2. Interaction of B. anthracis Sterne with hBMEC. B. anthracis Sterne (A) adheres to and (B) invades hBMEC. Data are expressed as the





respectively (C) Invasion of hBMEC by B. anthracis Sterne (B.a.) and closely-related B. thuringensis (B.t.) and B. subtilis (B.s.). (D) Concentration-
dependent inhibition of B. anthracis hBMEC invasion by cytochalasin D, a potent inhibitor of actin cytoskeleton rearrangements. All experiments were
repeated at least three times in triplicate, data from a representative experiment are shown. The error bars indicate 95% confidence intervals of the
mean of three wells.
doi:10.1371/journal.pone.0002964.g002
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anthracis lacking the pXO1 plasmid
Anthrax toxins are considered to be the major virulence factors
in B. anthracis infection. We therefore assessed the contribution of
the pXO1 plasmid, encoding anthrax toxins, to the hBMEC
transcriptional response. In parallel microarray studies, the B.
anthracis Sterne DpXO1 strain affected 121 hBMEC genes by more
than two-fold after 6 hours of infection compared to the
uninfected control (Fig. 3C, Table S1B). In contrast to infection
with the Sterne bacteria, only 38 out of 121 (31%) genes were
downregulated upon infection with DpXO1 bacteria (Fig. 3B, C).
The microarray data also show that mRNA levels for various
housekeeping genes like b-actin and GAPDH were similar for
samples infected with Sterne or the DpXO1 mutant (data not
shown). To visualize how the down- and upregulated genes of
Sterne-infected cells (colored blue and red, respectively, Fig. 3A)
were affected in DpXO1-infected cells, the same genes were
followed in the MA plot of DpXO1-infected hBMEC cells
compared to media control (Fig. 3B); 90% of genes were
differentially affected in response to bacteria that lacked pXO1
(Fig. 3B). Also 40 additional genes were more than two fold
induced in the absence of the pXO1 plasmid. Overall, this
indicates that the hBMEC transcriptional response is strongly
influenced by the presence of the pXO1 plasmid, whereas only
10% of the genes are regulated in a pXO1-independent manner
(Fig. 3A–C).
Since gene expression was strongly influenced by the pXO1
plasmid, we next sought to identify the most differentially regulated
genes in response to infection with Bacillus Sterne or DpXO1 mutant
strains. Figure 3D displays mean differences in gene expression
comparingDpXO1versus B.anthracisSterne infectedhBMEC; more
than two fold differentially down- and upregulated genes are colored
blue and red, respectively. The identity of these genes and their
expressioninhBMECcomparedtomediaaredisplayedinFigure4.
Analysis of differentially expressed genes by gene ontology (GO) of
molecular function indicated significant overrepresentation of genes
involved with transcription (p=1.3 610
212), growth (p=7.9 610
26),
RNA binding (p=1.7 610
25), protein kinase inhibition
Figure 3. MA plots and Venn-diagram comparing the transcriptional response in hBMEC upon infection with B. anthracis Sterne or
DpXO1 bacteria. MA plot showing the transcriptional profile of hBMEC upon infection with (A) B. anthracis Sterne vs. media control or (B) DpXO1
mutant bacteria vs. media control. Red and blue dots indicate genes that were more than two fold upregulated or downregulated, respectively upon
infection with Sterne bacteria. These same genes retain their color in panel B. (C) Venn diagram depicting the number of up- or downregulated that
were unique or overlapping in hBMEC upon infection with B. anthracis Sterne or DpXO1 mutant bacteria. (D) MA plot comparing gene expression of
DpXO1/B.a.Sterne; red and blue dots indicate genes that were more than two fold differentially induced or suppressed, respectively.
doi:10.1371/journal.pone.0002964.g003
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25), and cytokine activity (p=6.7 610
25). Of particular
interest however, was the observation that some of the most strongly
differentially affected genes were potent neutrophil chemoattractants
IL-8 (CXCL8), CXCL1 (Groa) and CXCL2 (Grob), since we have
previously shown that neutrophil recruitment is a major part of the
innate host defense response against bacterial infection [12]. This
wassupported byGOanalysisshowing significantdownregulationof
genes with chemokine activity (p=8.1 610
24) and correspondingly
genes involved in induction of positive chemotaxis (p=4.2 610
25)
and leukocyte activation (p=9.1 610
24). These microarray data
suggest that factors on the pXO1 plasmid may interfere with the
BBB innate immune defense, specifically neutrophil recruitment.
Confirmation of microarray expression data: quantitative
RT-PCR and ELISA
To confirm our microarray results we used quantitative RT-
PCR to analyze the relative transcript abundance in hBMEC of
the following genes involved in the host immune response: IL-6,
IL-8, CXCL1, CXCL2, and CCL20. Figure 5A depicts the
relative fold change in hBMEC transcript levels upon infection
with B. anthracis Sterne or DpXO1 mutant bacteria compared to
the uninfected control. As was observed in our microarray studies,
the transcript levels of IL-8, CXCL1 and CXCL2 were
significantly downregulated in cells infected with B. anthracis
Sterne compared to uninfected control or hBMEC infected with
the DpXO1 strain (Fig. 5A). In contrast, IL-6 and CCL20
transcripts were not downregulated in response to Sterne infection.
This response was not significantly different upon infection with
DpXO1 mutant bacteria, indicating that gene regulation for these
genes is independent of the presence of the plasmid.
Effects on gene transcription are not always paralleled by changes
in protein expression [19]. Therefore, we analyzed hBMEC
supernatants for the presence of IL-6, IL-8, CXCL1, CXCL2, and
CCL20 protein 6 hours after B. anthracis Sterne infection. Induction
of chemokines IL-8, CXCL1 and CXCL2 was markedly reduced
when cells were infected with the Sterne bacteria compared to
uninfected controls (Fig. 5B). In contrast, IL-6 and CCL20 protein
levels were unaffected and induced, respectively. Infection of
hBMEC with the DpXO1 strain restored secretion of IL-8 and
CXCL1 to levels secreted by uninfected cells, while IL-6, CXCL2,
and CCL20 protein expression levels did not differ in the absence of
the pXO1 plasmidcompared toB.anthracis Sterne-infected hBMEC,
suggesting that additional chromosomal factors may influence
protein expression (Fig. 5B). Overall, these independent experi-
ments generally confirmed our observations from the microarray
experiment and suggest a role for pXO1-encoded factors in the
downregulation of neutrophil chemokines in hBMEC.
Anthrax toxins inhibit expression of IL-8 and suppress
neutrophil recruitment in vivo
To establish whether anthrax toxins were responsible for the
downregulation of IL-8, the most potent and strongly affected
neutrophil chemokine, we utilized isogenic mutants that specifi-
Figure 4. Heatmap identifying genes with 2.2 fold differential
expression levels in hBMEC upon infection with B. anthracis
Sterne vs. DpXO1 mutant strain. Each column represents a
biological replicate microarray experiment upon infection with B.
anthracis Sterne (BA) or DpXO1 bacteria (pXO1). Red and Blue coloring
indicates induced or downregulated gene expression levels, respec-
tively, of infected hBMEC vs. media control. Expression clustering was
performed based on pairwise similarity, as described in Material and
Methods.
doi:10.1371/journal.pone.0002964.g004
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(B.a.) or DpXO1 mutant bacteria. (A) mRNA expression levels of IL-6, IL-8, CXCL1, CXCL2 and CCL20 in hBMEC upon infection with B. anthracis
Sterne (B.a.) or DpXO1 using quantitative RT-PCR. Fold change was determined as described in Material and Methods. Data represent mean and
standard deviation of three independent experiments performed in triplicate. (B) Protein expression of IL-6, IL-8, CXCL1, CXCL2 and CCL20 in hBMEC
supernatants 6 h post infection with B. anthracis Sterne (B.a.) or DpXO1 bacteria using ELISA. Experiments were performed three times in triplicate.
Bars represent mean and standard deviation of one representative experiment. * p,0.05, ** p,0.005, *** p,0.001.
doi:10.1371/journal.pone.0002964.g005
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Infection of hBMEC with the DLF/EF bacterial strain resulted in
a significant induction of IL-8 gene transcription (Fig. 6A) and
restoration of IL-8 protein secretion (Fig. 6B) compared to B.
anthracis Sterne infected cells. The presence of either LF or EF was
still sufficient to suppress IL-8 transcript and protein expression
(Fig. 6A, B), suggesting that both toxins are involved in
downregulation of this neutrophil chemokine.
As the anthrax toxins decreased neutrophil chemokine transcrip-
tion and expression, we hypothesized that neutrophil recruitment
might be suppressed after infection with B. anthracis Sterne compared
to the DLF/EF mutant strain. To examine the effects of anthrax
toxins on neutrophil chemotaxis in vivo, we analyzed neutrophil
recruitment to the site of infection using two independent assays.
First, neutrophil recruitment was assessed upon subcutaneous
injection of B. anthracis Sterne or the DLF/EF mutant strain into
the right or left flank of mice, respectively, After 4 hours, mice were
euthanized and the site of subcutaneous injection was excised,
homogenized and analyzed for the neutrophil enzyme myeloperox-
idase (MPO), which serves as an effective indicator of neutrophil
infiltration [20]. MPO levels and thereforeaccumulating neutrophils
were significantly lower upon infection with B. anthracis Sterne
compared to the DLF/EF mutant strain (Fig. 6C). Using a second
independent measurement, we quantified the amount of neutrophils
entering the peritoneal cavity upon i.p. injection of B.anthracis Sterne
or DLF/EF mutant bacteria. PBS and a 3% thioglycolate solution
were included as negative and positive controls, respectively. After
4 hours, cells were extracted from the peritoneal cavity and the
amount of accumulated neutrophils was quantified by flow
cytometry. Although neutrophils were recruited upon infection by
B. anthracis Sterne compared to the PBS control, neutrophil
accumulation was significantly reduced compared to the toxin-
deficient isogenic mutant (Fig. 6D). In general, neutrophil
accumulation by the DLF/EF mutant was comparable to the
positive 3% thioglycolate control (Fig. 6D). Overall, these results
suggest that B. anthracis anthrax toxins interfere with transcription
and secretion of neutrophil chemokines, as well as neutrophil
recruitment during active infection.
Anthrax meningitis mouse model
Our data suggest that B. anthracis is capable of penetrating the
BBB. In addition, anthrax toxins suppress the brain endothelial
Figure 6. Anthrax toxins impair IL8 expression and neutrophil chemotaxis (A) IL-8 mRNA expression levels upon infection with B.
anthracis Sterne (B.a.), DpXO1, DLF, DEF or DLF/EF mutant bacteria using quantitative RT-PCR. Data represent mean and standard
deviation of three independent experiments performed in triplicate. (B) Protein expression of IL-8 in hBMEC supernatants 6 h post infection with B.
anthracis Sterne, DpXO1, DLF, DEF or DLF/EF mutant bacteria using ELISA. Experiments were performed three times in triplicate. Bars represent mean
and standard deviation of one representative experiment. Neutrophil recruitment in vivo was assessed by measuring (C) myeloperoxidase (MPO)
activity in skin homogenates 4 h post infection or by (D) quantification of Gr-1+ cells upon peritoneal injection with B. anthracis Sterne (B.a.), toxin-
deficient bacteria (DLF/EF), PBS or thioglycolate positive control (TG). Bars indicate mean levels of neutrophil recruitment. ** p,0.005; *** p,0.001.
doi:10.1371/journal.pone.0002964.g006
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further dissemination of B. anthracis in the CNS. To test the
contribution of anthrax toxins to the pathogenesis of CNS
infection, we developed a mouse model of anthrax meningitis.
Mice were injected intravenously with B. anthracis Sterne or DLF/
EF bacteria (n=12 per group). Mice were euthanized when they
became moribund with severely labored breathing (between days
two and twelve for B. anthracis Sterne-infected mice) after which
brain and blood were collected. All of the DLF/EF-infected mice
and approximately 10% of the Sterne-infected mice survived until
the experimental endpoint of three weeks (Fig. 7A). Five out-of
eight Sterne-infected mice (63%) had high bacterial counts in the
brain (Fig. 7B), while no bacteria were recovered from the brains
of DLF/EF-infected mice (Fig. 7B). Microscopic examination of
brain tissue from mice infected with the Sterne strain showed
thickening of the meninges, an influx of inflammatory cells and
substantial hemorrhaging (Fig. 7D–F). In addition, Gram stain
revealed the presence of numerous bacilli in both the meninges
and the parenchyma (Fig. 7G, H). The brains of mice that were
infected with the DLF/EF strain did not show any signs of
infection over the course of the experiment and exhibited normal
brain architecture (Fig. 7C).
The absence of clinical symptoms in DLF/EF-infected mice
could partially be due to reduced virulence of this strain in vivo
[21]. Therefore, we performed additional in vitro experiments to
assess whether anthrax toxins contribute directly to the penetra-
tion of brain endothelium. Compared to the parent strain, the
toxin deficient strain exhibited a 70–80% reduction in hBMEC
invasion (Fig. 7I) and was less able to penetrate hBMEC
monolayers in a transmigration assay (Fig. 7J). Together these
data indicate that B. anthracis Sterne is indeed capable of crossing
the BBB in vivo, establishing the classic signs of meningitis and
meningoencephalitis, and that the expression of anthrax toxins
may directly contribute to this process.
Discussion
Infection with B. anthracis resulting in systemic disease is associated
with high morality characterized by septicemia, toxemia, and
meningitis [6,22–24]. The presence of bacilli in brain autopsies
indicates that vegetative bacteria are able to disseminate from the
bloodstreamtothe CNS,however,the basicpathogenicmechanisms
by which B. anthracis penetrates the BBB have not been described.
Using electron microscopy and an established in vitro model of the
BBB,wedemonstratehereforthefirsttimethatB.anthracisiscapable
of invading hBMEC, the single cell layer that comprises the BBB.
Our observations extend recent studies reporting invasion of B.
anthracis into non-phagocytic fibroblasts and epithelial cell lines [25].
Furthermore, our results suggest that uptake of B. anthracis Sterne in
hBMEC is specific and requires actin cytoskeleton rearrangements.
Interestingly, a very recent report identified a pXO1-encoded
adhesin, BslA important for adherence to keratinocytes and lung
epithelial cells [26]. Studies to identify and characterize additional
factors involved in hBMEC adherence and invasion, including the
BslA adhesin, are in progress.
We have used microarray analysis to examine the acute
response of brain endothelium to infection with vegetative B.
anthracis Sterne. We have shown previously that the BBB plays an
active role in initiating a very specific innate immune response to
bacterial infection by inducing gene expression of factors
promoting neutrophil recruitment [12]. Most strikingly, B. anthracis
infection reduced steady-state expression of 270 genes by more
than two-fold corresponding to 87% of all affected gene
transcripts. This contrasts typical host cellular responses to
microbial pathogens where the number of host genes induced by
infection is significantly higher than the number of down-regulated
genes [12,27]. The majority of downregulated genes were related
to transcription, signal transduction, stress, host immune response,
and proliferation. As anthrax toxins are the major secreted B.
anthracis virulence factors, we also analyzed the gene expression
profile of hBMEC upon infection with a strain lacking the pXO1
plasmid, DpXO1, which encodes both anthrax toxins. Ninety
percent of affected genes upon B. anthracis Sterne infection were
differentially affected upon infection with DpXO1 bacteria, and in
total only 31% of genes in DpXO1-infected cells were downreg-
ulated. Additionally, approximately 10% of genes were regulated
independently of pXO1, suggesting possible involvement of B.
anthracis chromosomal factors to host response. Overall, these
results suggest a major role for plasmid encoded factors and toxins
in regulating the brain endothelial host response.
Of particular interest was the unambiguous effect on the
expression levels of genes belonging to the CXC chemokine family,
particularly the neutrophil chemotactic factors IL-8, CXCL1 and
CXCL2 in response B. anthracis Sterne infection. Notably the
expression levels of other major pro-inflammatory mediators such as
TNFa and IL-1 were not affected by B. anthracis Sterne or DpXO1
infection. Neutrophil recruitment is thought to be part of the very
first line of CNS defense against bacterial infection [12] as many
Gram-positive and Gram-negative meningeal pathogens induce
expression of these genes in hBMEC [12,28], van Sorge et al.
unpublished data). Active impairment of neutrophil recruitment
could therefore benefit survival and proliferation of B. anthracis,a s
both spores and vegetative bacteria are efficiently killed by human
neutrophils [29]. Our results clearly demonstrate that the suppres-
sion of CXCL1 and IL-8 expression is pXO1- and toxin-dependent,
respectively. These data complement observations in recent studies
where systemic infection with the encapsulated strain impaired
production of cytokines in a toxin-dependent manner [30] and
purified LT reduced IL-8 production by the destabilization of IL-8
mRNA in HUVEC in vitro [31].
We hypothesized that altered chemokine expression would result
in impaired neutrophil recruitment upon active infection with B.
anthracis Sterne. Using two independent in vivo assays, we
demonstrated that neutrophil chemotaxis was indeed reduced to
the site of infection with the Sterne strain as compared to infection
with the DLF/EF mutant. Similar observations were recently
published in a systemic infection model using encapsulated WT B.
anthracis (pXO1
+, pXO2
+); host neutrophil recruitment in spleen and
liver was significantly increased in the absence anthrax toxins
compared to infection with the parent strain [32]. In addition,
purified LT has been shown to directly impair neutrophil motility
[33,34]. Toxin-mediated subversion of the innate immune system,
specifically targeting neutrophils, may therefore contribute to
uncheckedbacterialreplicationand amorefulminentdiseasecourse.
Establishment of an anthrax meningitis model is critical to
better understand disease pathogenesis. The current rabbit and
rhesus monkey models of inhalation anthrax [7,35] both report
signs of meningitis in a subgroup of animals, however, a mouse
model would be preferable due to availability, lower costs and
well-characterized genetic systems. We found that intravenous
injection of immunocompetent outbred CD-1 mice with B.
anthracis Sterne resulted in penetration of bacilli into the CNS.
Microscopic analysis of brain sections confirmed the development
of meningitis, showing inflammatory cell infiltration, hemorrhag-
ing, thrombosis, edema and areas full of bacilli. While we did
observe neutrophil infiltration in the brains of B. anthracis Sterne
infected mice at the time of death, we speculate that an initial
reduction or delay in host neutrophilic response may promote
Toxins and Anthrax Meningitis
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dissemination ultimately responsible for the rapidly progressive
deteriorating course associated with anthrax meningitis. These
observations reflect autopsy findings in patients [5] validating the
utility of this newly developed mouse model of hematogenous
anthrax meningitis. Finally, development of anthrax meningitis
requires expression of anthrax toxins as no signs of disease
developed in mice infected with the DLF/EF mutant strain.
Figure 7. Mouse model of anthrax meningitis. (A) Kaplan-Meier survival curve of mice upon infection with B. anthracis Sterne (filled squares) or
DLF/EF (open circles) bacteria. Groups of CD-1 mice (n=12 per group) were injected intravenously with 2–3610
4 CFU of bacteria and survival was
monitored at least twice a day over a three-week period. (B) Bacterial counts in brain at time of death of mice infected with B. anthracis Sterne (B.a.)
or D LF/EF. Bar represents median bacterial number in the group of mice. Histopathology of (C–F) H&E- or (G, H) Gram-stained brain tissues of
representative individual mice. (C) Sample from a mouse infected with DLF/EF bacteria showing normal brain architecture and no inflammation.
Samples from mice infected with B. anthracis Sterne showing (D, E) meningeal thickening and cellular infiltration and (F) hemorrhaging. (G, H) Gram
stain of a mouse infected with B. anthracis Sterne showing high levels of bacilli in the parenchyma. (I) Invasion and (J) transmigration of hBMEC by B.
anthracis Sterne (B.a.) or DLF/EF bacteria. * p,0.05; ** p,0.005; *** p,0.001.
doi:10.1371/journal.pone.0002964.g007
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direct contribution of the toxins to penetration of brain
endothelium; however, we cannot exclude the possibility that the
lack of clinical symptoms observed during infection with the toxin-
deficient mutant may partially reflect a generalized reduction in
virulence.
In summary, our studies provide the first evidence that B. anthracis
is capable of invading the human BBB. We have also demonstrated
that diverse functional classes of genes, including chemokines
involved in neutrophil recruitment and signaling, were downregu-
lated in brain endothelium upon B. anthracis infection suggesting that
the pathogen actively suppresses the BBB innate immune response.
This signaling appears to be mediated largely by the bacterial
pXO1-encoded toxins. Our in vivo studies indicate that the anthrax
toxins contribute to impaired neutrophil recruitment and the
development of anthrax meningitis. Additional studies aimed at
further understanding the mechanisms governing the pathogenesis
of anthrax meningitis should aid in the development of preventative
therapies for this serious CNS infection.
Materials and Methods
Bacterial strains and endothelial cell culture
Bacillus anthracis Sterne (pXO1
+, pXO2
2) and mutant deriva-
tives were grown in Brain-Heart infusion broth (BHI; Sigma) as
shaking cultures under aerobic conditions at 37uC. B. anthracis
Sterne was cured of the pXO1 plasmid by passage at 43uC.
Specific LF, EF and LF/EF deletion mutants were generously
provided by Scott Stibitz (Center for Biologics Evaluation and
Research, Bethesda, Maryland) and described previously [36]. For
log-phase cultures of B. anthracis, fresh BHI was inoculated with the
overnight culture at a 1:20 dilution and grown to OD600=0.4
(1610
7 CFU/ml). Growth kinetics of all strains was similar under
the experimental conditions used in our assays.
The human brain microvascular endothelial cell line hBMEC,
obtained from Kwang Sik Kim (Johns Hopkins University,
Baltimore, Maryland, USA), were originally isolated as previously
described [13,37], and maintain the morphologic and functional
characteristics of primary brain endothelium [13,15]. HBMEC
were cultured using RPMI 1640 (Gibco), supplemented with 10%
fetal calf serum (FBS; Gibco), 10% Nuserum (BD Biosciences, San
Jose, California, USA), and modified Eagle’s medium nonessential
amino acids (Gibco) without addition of antibiotics. All experi-
ments used cells at passage 8–14.
HBMEC infection and transmigration assays
For hBMEC invasion assays, cells were seeded in collagen-
coated 24 well tissue culture plates until they reached 90–100%
confluency. B. anthracis cultures were grown to log-phase as
described above. Log-phase bacteria were pelleted, washed in PBS
and resuspended in RPMI 1640 10% FBS to the appropriate
concentration. HBMEC monolayers, washed twice with PBS
before the addition of bacterial cultures, were infected with
different multiplicity of infection (MOI; MOI of 1 is approximately
1610
5 CFU) in a final volume of 500 ml of RPMI 10% FBS. Plates
were centrifuged at 8006g for 5 min to synchronize the infection,
and subsequently incubated at 37uC with 5% CO2. After 2–4 h,
monolayers were washed three times with PBS before the addition
of 1 ml of RPMI 10% FBS containing 50 mg of gentamicin for
15 min to kill extracellular bacteria. Control experiments
confirmed that B. anthracis was killed by this concentration of
gentamicin within 15 minutes (data not shown). The monolayers
were washed three times with PBS before the addition of 0.1 ml of
0.25% trypsin/EDTA solution (5 min 37uC) followed by 0.4 ml of
0.025% Triton X-100 to liberate intracellular bacteria. The
number of invasive bacteria was quantified by plating serial
dilutions of the lysate on THB or BHI agar plates. To assess the
effect of host cytoskeleton on B. anthracis invasion, hBMEC cells
were incubated for 30 min with the indicated concentration of
cytochalasin D (Sigma) before addition of bacteria. To assess the
level of surface-adherent (total cell-associated) bacteria, bacteria
were quantified from hBMEC monolayers prior to addition of
extracellular antibiotics after 45 min of incubation as described
above only washing six times with PBS prior to bacterial
enumeration. All cellular adherence and invasion assays were
performed at least in triplicate and repeated at least three times.
For transmigration assays, polar hBMEC monolayers were
established on collagen-coated Transwell plates, 3 mm pore size
(Transwell-COL; Corning-Costar Corp., MA, USA) as described
previously [16]. Monolayers were incubated with 2610
5 CFU of
log-phase grown bacteria. After 4 hours, the number of bacteria in
the lower chamber was quantified by serial dilution plating on
THA plates. The experiment was performed at least three times in
triplicate.
Transmission electron microscopy
Infection experiments were performed similar to the adherence
assay described above with B. anthracis Sterne for 1 hour or
4 hours. After washing, samples were immersed in modified
Karnovsky’s fixative (1.5% glutaraldehyde, 3% paraformaldehyde
and 5% sucrose in 0.1 M cacodylate buffer, pH 7.4) for at least
8 hours, post fixed in 1% osmium tetroxide in 0.1 M cacodylate
buffer for 1 hour and stained en loc in 1% uranyl acetate for
1 hour. Samples were dehydrated in ethanol, embedded in epoxy
resin, sectioned at 60 to 70 nm, and picked up on carbon-coated
formvar grids. Grids were stained with uranyl acetate and lead
nitrate, viewed using a JEOL 1200EX II (JEOL, Peabody, MA) or
Philips CM-10 (FEI, Hilsboro, OR) transmission electron
microscope and photographed using a Gatan digital camera
(Gatan, Peabody, CA).
Microarray analysis
Microarray experiments were performed using Sentrix Human-
8 Expression BeadChips, which analyzed 25,440 transcripts
(Illumina, San Diego, CA) according to manufacturer’s instruc-
tions. In brief, a 250 ng aliquote of total RNA, isolated as
described above, from each sample was amplified to cDNA,
transcribed to cRNA and biotin labelled using Ambion’s
TotalPrep kit (Austin, TX), according to the instructions. cRNA
concentrations were checked with the Agilent Bioanalyzer, and
cRNA quality was controlled by BioRad’s Experion Automated
Electrophoresis System and RNA Std Sens Analysis Kit (BioRad
Laboratories, Hercules, CA). Each sample cRNA (750 ng) was
hybridized to Illumina’s Sentrix Human-8 Expression BeadChip
arrays at 58uC overnight (18 h, shaking) following the Illumina
Whole-Genome Gene Expression Protocol for BeadStation.
Hybridized biotinylated cRNA was detected with 1 mg/ml
streptavidin-Cy3 (Amersham Biosciences, Piscataway, NJ). Bead-
Chips were scanned with Illumina BeadArray Reader. Data was
analyzed using a statistical algorithm developed for high-density
oligonucleotide arrays [38].
RNA isolation, cDNA preparation and qPCR
HBMEC monolayers were infected with B. anthracis Sterne, or
isogenic mutants (DpXO1, DLF, DEF, or DLF/EF) for 6 hour.
Total RNA was extracted using the RNeasy kit (Qiagen, Valencia,
CA) according to the manufacturer’s instruction, and 1 mg of RNA
reverse transcribed to cDNA (Superscript First-strand synthesis kit,
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following primer sets: IL-6 forward primer 59- GGA GAC TTG
CCT GGT GAA AA -39 and IL-6 reverse primer 59- CAG GGG
TGG TTA TTG CAT CT -39, IL-8 forward primer 59- AGC
TCT GTG TGA AGG TGC AG - 39 and IL-8 reverse primer 59-
AAT TTC TGT GTT GGC GCA GT - 39, CXCL1 forward
primer 59 - CTC TTC CGC TCC TCT CAC AG - 39, and
CXCL1 reverse primer 59 - GGG GAC TTC ACG TTC ACA
CT -3, CXCL2 forward primer 59- CTC AAG AAT GGG CAG
AAA GC -39, and CXCL2 reverse primer 59- AAA CAC ATT
AGG CGC AAT CC -39, CCL20 forward primer 59- GCG CAA
ATC CAA AAC AGA CT -39 and CCL20 reverse primer 59-
CAA GTC CAG TGA GGC ACA AA -39, and GAPDH forward
primer 59- GAA GGT GAA GGT CGG AGT CAA CG -39 and
GAPDH reverse primer59- TCC TGG AAG ATG GTG ATG
GGA T -39. PCR reaction mixtures contained primers at a
concentration 10 mM and PCR mix (SYBR GreenER qPCR
Supermix for iCycler, Invitrogen) in a volume of 25 ml. qPCR
cycling was as follows for all genes: 50uC for 2 min, 95uC for
7 min, followed by 40 cycles of 95uC for 150 and 61uC for 1 min.
Melting curve analysis was performed according to the manufac-
turer’s instructions; PCR primer efficiencies were as follows: 1.92
for IL-6, 1.8 for IL-8, 1.83 for CXCL1, 1.99 for CXCL2, 1.94 for
CCL20 and 1.88 for GAPDH. Calculation of relative gene
expression included adjustments for PCR efficiencies and using the
following equation: Relative gene expression=target gene effi-
ciency6(CT control - CT sample)/1.886(CT control - CT sample).
Chemokine secretion in hBMEC supernatants
HBMEC supernatants were collected after infection with B.
anthracis Sterne, DpXO1, DLF, DEF, or DLF/EF deletion mutants
after 6 hours. Concentrations of IL-8 (R&D systems, Minneapolis,
MN, USA), CXCL1 (R&D systems), CXCL2 (BioSupplyUK) and
CCL20 (R&D systems) were measured using enzyme-linked
immunosorbent assays (ELISA) according to the manufacturer’s
instructions. IL-6 and IL-8 concentrations were measured using
the cytometric bead array system according to the manufacturer’s
instructions (BD Biosciences, Human inflammation kit).
Mouse infection studies
All animal experiments were approved by the Committee on the
Use and Care of Animals, and performed using accepted veterinary
standards. For the meningitis model, bacteria were grown to early
log phase, washed in PBS and resuspended to an optical density of
0.4 in PBS. Vegetative bacteria were diluted in PBS to 2–3610
5
CFU/ml and 0.1 ml was injected intravenously into 8 weeks old out
bred immunocompetent female CD-1 mice (Charles River Labora-
tories, Wilmington, MA, USA). Mice were monitored for signs of
infection at least twice a day for up to three weeks and euthanized
when they became moribund. Blood and brain were collected and
plated to determine bacterial counts. Half of the brain was stored in
10% formalin for further histology analysis performed at the UCSD
Histopathology Core Facility (N. Varki, Director).
Todetermineneutrophilrecruitmentinvivo,B.anthracisSterneand
DLF/EF mutant bacteriaweregrowntoearlylogphase,washedand
resuspended in PBS to and OD600=0.4. Eight week old CD-1
female mice were injected with 1610
6 CFU of B. anthracis Sterne on
the right shaved flank and with 1610
6 CFU of DLF/EF mutant
bacteriaon theleftshavedflankina volumeof 0.1 ml.After4 hours,
mice were euthanized and the site of subcutaneous injection was
excised for further analysis of myeloperoxidase activity (see below).
Neutrophil recruitment was also assessed using an intraperitoneal
infection model. Eight week old CD-1 female mice were injected i.p.
with 2610
6 CFU in 200 ml PBS. PBS alone and a 3% thioglycolate
solution were used as negative and positive control for neutrophil
recruitment, respectively. After 4 hours, cells were harvested from
the peritoneal cavity in PBS 0.2% BSA. One-hundred mlo fc e l l
suspension was directly stained with FITC-labeled rat anti-mouse
Gr-1 monoclonal antibody or the appropriate isotype control (both
BD Pharmingen) for 30 min at 4uC and analyzed by flow cytometry.
The flow cytometer was set to count events during a fixed time (60 s)
thus permitting quantification of the absolute number of recovered
Gr-1 positive cells in each mouse [39]. A quality check was
performed on the flow cytometer (Dual Laser FACSCalibur Flow
Cytometer) before use to assure a constant flow rate.
Myeloperoxidase assay
Skin samples of mice were homogenized in 500 ml 0.05%
hexadecyltrimethylammonium bromide (HTAB in 0.05 M phos-
phate buffer, pH 6; Sigma) solution. Homogenates were centri-
fuged for at 18,0006 g for 30 min at 4uC. Supernatants were
transferred to a clean microcentrifuge tube and stored at 280uC
until further analysis. Next, 10 mg of o-dianisidine dihydrochloride
(DCC; Sigma) was added to 60 ml of freshly-prepared HTAB
solution to yield DCC solution. In addition, activated substrate
was prepared by adding one ml of 0.05% hydrogen peroxide
solution for every 99 ml of DCC solution. Finally, the reaction was
started by adding 90 ul of DCC solution in HTAB solution and
100 ml of activated solution to 10 ml of skin supernatants 96 well
flat-bottom plates. The absorbance was read every minute for
10 minutes at 450 nm using a spectrophotometer. All samples
were analyzed in triplicate. For quantification purposes, a
calibration curve of horseradish peroxidase (Calbiochem) ranging
from 100 mU/ml to 3.13 mU/ml was run in parallel with the
samples in triplicate with every experiment.
Statistical analysis
Graphpad Prism version 4.03 was used for statistical analysis.
Differences in adherence/invasion, mRNA expression, chemokine
secretion in hBMEC supernatants were evaluated with a one-way
ANOVA followed by Tukey’s post hoc test. Differences in
neutrophil recruitment were determined using a paired t-test for
the MPO assay and an unpaired t-test for the intraperitoneal
infection model. Kaplan-Meier survival plots were evaluated with
the log-rank test. Statistical significance was accepted at p,0.05.
Supporting Information
Table S1 A. Genes affected in hBMEC .2 fold by infection
with B. anthracis Sterne B. Genes affected in hBMEC .2 fold by
infection with pXO1 deficient mutant
Found at: doi:10.1371/journal.pone.0002964.s001 (0.07 MB
XLS)
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